Show from 4/24/20

Wharton Finance Professor Jeremy Siegel starts off the show with a market update discussing recent oil prices and anti-viral medication news. Then Hosts Jeremy Schwartz, Jeremy Siegel and Liqian Ren interview Dr. Kevin Volpp from the Perelman School of Medicine to discuss the medical research being done to combat COVID-19. According to Dr. Volpp, there need to be more careful clinical studies conducted with real control groups to ensure potential treatments do not harm patients. He also notes that Penn Medicine is working on clinical trials, vaccine development, and a Google based chat bot that can be placed on health portals to help with predictive modeling.

Guest:

Dr. Kevin Volpp - Founders President’s Distinguished Professor of Medicine and Medical Ethics and Policy at the Perelman School of Medicine and Health Care Management at the Wharton School. He is also the founding Director of the Center for Health Incentives and Behavioral Economics (CHIBE), Vice Chairman for Health Policy for the Department of Medical Ethics and Policy, and Director (with Karen Glanz) of the Penn CDC Prevention Research Center.

For more information on Dr. Volpp: https://chibe.upenn.edu/faculty-members/kevin-volppmd-phd/

See acast.com/privacy for privacy and opt-out information.